Desk›Chemicals› Sudeep Pharma Ltd
Sudeep Pharma Ltd
BSE 544619 · NSE SUDEEPPHRM · ISIN INE0QPI01025 · Group B · Active
Commodities › Chemicals › Chemicals & Petrochemicals › Specialty Chemicals
₹1,152.75
+1.84%
BSE close, 28 August 2026
₹13,020.15 cr
11.3 cr shares · Small cap
₹3,105.02 cr
as published
112.0× · —
EPS ₹10.29 · BV —
338.51 / 107.58
₹ cr, as filed
19
7 selected · 37%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -3.1% |
|---|---|
| Against 52-week low | +119.6% |
| Day change | +1.84% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹10.29 |
|---|---|
| Price / earnings | 112.03× |
| Price / book | — |
| Book value — derived, price ÷ P/B | — |
| Return on equity | — |
| Operating margin | 46.36% |
| Net margin | 32.01% |
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 105.68 | 33.83 | 3.00 | 46.36% | 32.01% |
| Mar-26 · Q | 80.17 | 25.77 | 2.31 | 48.03% | 32.14% |
| FY25-26 | 338.51 | 107.58 | 9.65 | 46.76% | 31.78% |
Quarter on quarter
- Revenue, quarter on quarter
- +31.8%
- Net profit, quarter on quarter
- +31.3%
- Operating margin, quarter on quarter
- -167 bps
Disclosure profile 19 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Investor Presentation | 3 |
| Board Outcome | 1 |
| Change in Management | 1 |
| Concall Transcript | 1 |
| Results | 1 |
| Selected sub-total | 7 |
| Procedural | |
| Analyst / Investor Meet | 5 |
| AGM / EGM | 2 |
| General | 2 |
| Compliance Certificate | 1 |
| Newspaper Publication | 1 |
| Trading Window | 1 |
| Procedural sub-total | 12 |
| Total | 19 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
19 filings · 7 selected · busiest 2026-08-04
Filing rhythm · the twelve most recent
2026-08-042026-10-07
SelectedProcedural
Filings
19 in the window · 8 earlier on record
-
7 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Compliance Certificate under Regulation 74 (5) of SEBI (DP) Regulation as on 30.09.2026
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
5 October 2026 ·
Change in Management
We wish to inform the changes in the SMP of the Company, arising due to completion of contractual arrangements between the company and Mr. Sendhil Pani, Managing Director of Sudeep Pharma ....
Company Update / Change in Management View filing →
-
25 September 2026 ·
Closure of Trading Window
Intimation for Closure of Trading window w.e.f. 1st October 2026
Insider Trading / SAST / Closure of Trading Window View filing →
-
23 September 2026 ·
Analyst / Investor Meet - Intimation
This is to inform that the officials of the Company will be attending the Investor Conference organized by Nuvama Emerging India CEO Forum 2026 on 28th September 2026 at 10:00 a.m. in Mumbai.
Company Update / Analyst / Investor Meet View filing →
-
22 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation on Cancellation of scheduled Investor /Analyst Meet
Company Update / Analyst / Investor Meet View filing →
-
16 September 2026 ·
Analyst / Investor Meet - Intimation
we would like to inform that the officials of the Company has arranged a plant visit (Gujarat) for Investors/Analysts (Participants) on 23rd & 24th September 2026.
Company Update / Analyst / Investor Meet View filing →
-
11 August 2026 ·
Earnings Call Transcript
Submission of Earnings Call Transcript for the call held on 05.08.2026
Company Update / Earnings Call Transcript View filing →
-
6 August 2026 ·
-
5 August 2026 ·
Analyst / Investor Meet - Outcome
Submission of Audio Recording of Earnings Call held on 05.08.2026
Company Update / Analyst / Investor Meet View filing →
-
5 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Submission of E-voting and Scrutinizer's Report for the 37th Annual General Meeting held on 04.08.2026
AGM/EGM / AGM View filing →
-
5 August 2026 ·
Newspaper Publication
Submission of newspaper publication of Financials as on 30.06.2026
Company Update / Newspaper Publication View filing →
-
4 August 2026 ·
Investor Presentation
Submission of revised Investors Presentation
Company Update / Investor Presentation View filing →
-
4 August 2026 ·
Investor Presentation
Submission of Investors Presentation
Company Update / Investor Presentation View filing →
-
4 August 2026 ·
Investor Presentation
Submission of Investors Presentation
Company Update / Investor Presentation View filing →
-
4 August 2026 ·
Unaudited Financials As On 30.06.2026
Submission of Financials as on 30.06.2026
Result / Financial Results View filing →
-
4 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting
Submission of Outcome of Board Meeting
Board Meeting / Outcome of Board Meeting View filing →
-
4 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Submission of proceedings of the 37th Annual General Meeting held on 4th August 2026
AGM/EGM / AGM View filing →
-
29 July 2026 ·
Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nuvama Crossover Opportunities Fund ....
Company Update / General View filing →
-
27 July 2026 ·
Analyst / Investor Meet - Intimation
Intimation for Earnings call to be held on Wednesday, 5th August 2026
Company Update / Analyst / Investor Meet View filing →
RSS feed for Sudeep Pharma Ltd · the 50 most recent filings